Floatz logo

890 assets in Neoplasm

Therapeutic assets addressing Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Bbo-10203
Neoplasm
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)P1CC (43)
Ceralasertib
Neoplasm
AstraZenecaP1CC (43)
com503
Neoplasm
Compugen LtdP1CC (43)
ct-95
Neoplasm
Context Therapeutics Inc.P1CC (43)
dxc014
Neoplasm
Hangzhou DAC Biotechnology Co., Ltd.P1CC (43)
Engineered Mitochondrial Vaccine
Neoplasm
West China HospitalP1CC (43)
eo-3021
Neoplasm
Elevation OncologyP1CC (43)
eos006215
Neoplasm
iTeos Belgium SAP1CC (43)
Fam-Trastuzumab Deruxtecan-Nxki
Neoplasm
QuantumLeap Healthcare CollaborativeP1CC (43)
Furosemide
Neoplasm
M.D. Anderson Cancer CenterP1CC (43)
GEH200520
Neoplasm
GE HealthcareP1CC (43)
GEH200521 (18F)
Neoplasm
GE HealthcareP1CC (43)
Gilteritinib
Neoplasm
Kura Oncology, Inc.P1CC (43)
iam1363
Neoplasm
Iambic Therapeutics, IncP1CC (43)
Idarubicin
Neoplasm
Kura Oncology, Inc.P1CC (43)
imm27m
Neoplasm
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.P1CC (43)
imm40h
Neoplasm
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.P1CC (43)
Immunoglobulin G1 (134-Cysteine,228-Valine,242-Phenylalanine,243-Glutamic Acid,339-Serine,362-Cysteine,374-Tryptophan), Anti-(Human Cytotoxic T-Lymphocyte-Associated Protein 4) (Human Monoclonal Medi5752 .Gamma.1-Chain), Disulfide With (122-Cysteine,212-Valine) Human Monoclonal Medi5752 .Lambda.-Chain, (234->231')(237->234')(362->354') Tris(Disulfide) With Immunoglobulin G1 (239-Phenylalanine,240-Glutamic Acid,336-Serine,354-Cysteine,371-Serine,373-Alanine,412-Valine) Anti-(Human Programmed Cell Death Protein 1) (Human-Mus Musculus Monoclonal Medi5752 .Gamma.1-Chain) Disulfide With Human-Mus Musculus Monoclonal Medi5752 .Kappa.-Chain
Neoplasm
MedImmune LLCP1CC (43)
jmt108
Neoplasm
Conjupro Biotherapeutics, Inc.P1CC (43)
Kln-1010
Neoplasm
Kelonia Therapeutics, Inc.P1CC (43)
LXP1788
Neoplasm
LaunXP Biomedical Co., Ltd.P1CC (43)
m28z1xxpd1dnr car
Neoplasm
Memorial Sloan Kettering Cancer CenterP1CC (43)
Mechanobiologically Reprogrammed Macrophage-Derived Exosomes
Neoplasm
West China HospitalP1CC (43)
Modified Vaccinia Virus Ankara Vaccine Expressing P53
Neoplasm
City of Hope Medical CenterP1CC (43)
Mst-0312
Neoplasm
Mestag Therapeutics LimitedP1CC (43)
Neoantigen Personalized Cancer Vaccine
Neoplasm
Ruijin HospitalP1CC (43)
Nogapendekin Alfa Inbakicept
Neoplasm
National Cancer Institute (NCI)P2CC (43)
Nst-628
Neoplasm
Nested Therapeutics, IncP1CC (43)
nw-301vt
Neoplasm
Zhejiang UniversityP1CC (43)
Obx-115
Neoplasm
M.D. Anderson Cancer CenterP1CC (43)
Oricar-017
Neoplasm
OriCell Therapeutics Co., Ltd.P1CC (43)
(R)-2-((1-(2-(4-Methoxy-3-(2-Morpholinoethoxy) Phenyl)-5-Methylthiazol-4-Yl)Ethyl)Thio)Pyrimidine-4,6-Diamine
Neoplasm
TretheraP1CC (43)
Rimiducid
Neoplasm
M.D. Anderson Cancer CenterP1CC (43)
RO7567132
Neoplasm
Hoffmann-La RocheP1CC (43)
SAR443216
Neoplasm
SanofiP1CC (43)
Sibp-A18
Neoplasm
Shanghai Institute Of Biological ProductsP1CC (43)
Suvonstobart
Neoplasm
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.P1CC (43)
sys6040 for
Neoplasm
CSPC Megalith Biopharmaceutical Co.,Ltd.P1CC (43)
Tucatinib
Neoplasm
QuantumLeap Healthcare CollaborativeP1CC (43)
xl495
Neoplasm
ExelixisP1CC (43)
Ziftomenib
Neoplasm
Kura Oncology, Inc.P1CC (43)
Zirconium Zr 89-Dfo-Ys5
Neoplasm
Robert Flavell, MD, PhDP1CC (43)
es102
Neoplasm
Elpiscience Biopharma, Ltd.P1CC (42)
H-Gamma1 Heavy Chain Homo Sapiens (1-447) [Vh (Homo Sapiens Ighv4-59*01 (99.0%) -(Ighd) -Ighj3*02 (93.3%) T125>I (114), Cdr-Imgt [8.7.11] (26-33.51-57.96-106)) (1-117) -Homo Sapiens Ighg1*01, G1M17,1 Ch1 K120, Ch3 D12, L14, 9-G1V21 Ch2 Y15.1, T16, E18 (Ch1 K120 (214) (118-215), Hinge 1-15 (216-230), Ch2 M15.1>Y (252), S16>T (254), T18>E (256) (231-340), Ch3 D12 (356), L14 (358) (341-445), Chs (446-447)) (118-447)], (220-214')-Disulfide With L-Kappa Light Chain Homo Sapiens (1'-214') [V-Kappa (Homo Sapiens Igkv3-11*01 (96.8%) -Igkj4*01 (100%), Cdr-Imgt [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo Sapiens Igkc*01 (100%) Km3 A45.1, V101 (Ckappa A45.1 (153'), V101 (191')) (108'-214')]; Dimer (226-226'':229-229'')-Bisdisulfide, Produced In A Cell Line Derived From Chinese Hamster Ovary (Cho) Cells, Glycoform Alfa
Neoplasm
Kineta Inc.P1/2CC (42)
ibi129
Neoplasm
Innovent Biologics (Suzhou) Co. Ltd.P1/2CC (42)
Jab-Bx102
Neoplasm
Jacobio Pharmaceuticals Co., Ltd.P1/2CC (42)
Lodapolimab
Neoplasm
Eli Lilly and CompanyP1CC (42)
Magrolimab
Neoplasm
Gilead SciencesP2CC (42)
rc88
Neoplasm
RemeGen Co., Ltd.P1/2CC (42)
Tovorafenib
Neoplasm
Day One Biopharmaceuticals, Inc.P2CC (42)
Showing 301 to 350 of 890 assets
PreviousPage 7 of 18Next